Blood tests as a screening tool for Alzheimer's disease
Part of Mental health clinical trials.
This study compares a new blood test with the standard spinal tap to see if it can help diagnose Alzheimer's disease. It is for people who are already scheduled for a spinal tap as part of their memory evaluation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 50 and 80.
- You are fluent in Italian.
- You do not have other brain diseases like a tumor or stroke that could affect memory.
- You do not have a serious mental health condition like schizophrenia.
- You do not have a history of alcohol abuse.
- You are not taking blood thinners and do not have a spine condition that would prevent a spinal tap.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a simple blood test to the standard spinal tap for detecting Alzheimer’s disease. If your doctor already plans a spinal tap to check for Alzheimer’s, you may be able to help by also giving a blood sample.
This study looks at whether a simple blood test can help doctors detect Alzheimer's disease early, even before symptoms are clear. It is designed for people who are worried about their memory or thinking and want to find out more.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether blood-based markers can help identify Alzheimer's disease earlier. It is for people with Alzheimer's, mild memory problems, or no memory issues at all.
This study uses a simple blood test to quickly detect Alzheimer's-related brain changes (amyloid plaques). It may help people with memory concerns avoid a more invasive PET scan and get answers faster.
This study is testing a simple blood test (p-Tau217) as a possible way to diagnose Alzheimer's disease. If it works, it might replace the need for a spinal tap. The results will be compared with the usual spinal fluid markers.
Hear when a new Cognitive Decline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.